This inventor holds 2 USPTO granted patents. Top assignees: Affibody Technology Sweden Ab, Avant Immunotherapeutics, Inc.. Active years: 1999-2001.
Location History:
- Hagersten, SE (1999)
- Hägersten, SE (2001)
Company Filing History:
Years Active: 1999-2001
Title: The Innovations of Hans Wigzell
Introduction
Hans Wigzell is a notable inventor based in Hägersten, Sweden. He has made significant contributions to the field of biomedicine, particularly in the development of protein and peptide conjugates. With a total of 2 patents, his work has the potential to impact therapeutic treatments significantly.
Latest Patents
Wigzell's latest patents include a method for creating stabilized protein or peptide conjugates that can bond with albumin, resulting in extended biological half-lives. This innovative process involves covalently coupling a biologically active protein or peptide to a polypeptide fragment that binds to serum proteins. The resulting conjugate demonstrates extended biological activity when administered, making it a promising candidate for manufacturing medicaments that show prolonged half-life in vivo. Additionally, he has developed a method for the therapeutic or prophylactic treatment of sarcoidosis.
Career Highlights
Throughout his career, Hans Wigzell has worked with various companies, including Affibody Technology Sweden AB and Avant Immunotherapeutics, Inc. His expertise in biomedicine has allowed him to contribute to advancements in therapeutic treatments and drug development.
Collaborations
Wigzell has collaborated with notable colleagues such as Per Åke Nygren and Mathias Uhlén. These partnerships have further enhanced his research and development efforts in the field.
Conclusion
Hans Wigzell's innovative work in the development of protein and peptide conjugates showcases his significant contributions to biomedicine. His patents and collaborations reflect a commitment to advancing therapeutic treatments, making him a prominent figure in the field.